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Articular cartilage is frequently altered upon trauma or in osteoarthritis (OA), a degenerative disease that is currently incurable. Cartilage tissue engineering/cell therapy offer new insights to cure 
these articular disorders. Since the first generation of cartilage tissue engineering led to a poor quality cartilage rich in the hyaline cartilage atypical type I collagen, it has been followed with improved 
generations. One way to improve these strategies was to diversify the cell type used. Mesenchymal stem cells (MSC) are considered as an interesting cell type in order to produce a hyaline cartilage 
substitute. This study aimed to compare umbilical cord blood (UCB) and bone marrow (BM) derived MSC. 
BM and UCB MSC were isolated and then amplified in monolayer culture. We characterized MSC by assessing their proliferative and multipotence capacities, and the presence of cluster of 
differentiation (CD) characteristic of MSC. Then, we compared MSC at their basal state and after a chondrogenic differentiation, which consisted of culture in hypoxia or normoxia in a biomaterial, 
with chondrogenic factors (BMP-2, TGF-ß1). Criteria used to compare MSC were the mRNA level and protein amount of several osteogenic (osteocalcin/Runx2), hypertrophic (type X collagen) and 
chondrogenic markers (type II collagen). Furthermore, we analysed the extracellular matrix(ECM) composition/structure by immunochemistry. 
Introduction 
Results 
Conclusions 
Although samples of BM and UCB allow the isolation of cells possessing MSC characteristic, differences can be observed between the two sources without predicting a better chondrogenic 
potential for a MSC source rather the other. mRNA and protein analyses of undifferentiated MSC suggest a stronger possibility for BM MSC to synthesize collagens compared to UCB MSC, which 
is attractive considering their use in cartilage tissue engineering. Nevertheless, BM MSC express also a higher amount of hyaline cartilage atypical molecules such as osteocalcin and type I 
collagen, to a greater extent than UCB MSC. Both MSC were able to produce a hyaline like cartilage matrix upon a chondrogenic differentiation protocol. However, considering that type I collagen is 
the major unwanted component in the in vitro cartilage synthesis, BM MSC seem to be the best MSC candidate for cartilage tissue engineering with the in vitro chondrogenic differentiation protocol 
used here. However, the decrease of the type I collagen protein amount only observed in UCB MSC at D28, even if it remains higher than BM MSC, could only be the beginning of the decrease. 
Thus, by lenghtening the time of the chondrogenic differentiation protocol, UCB could also be an attractive MSC source for cartilage tissue engineering. 
Equine UCB was collected by venipuncture of the umbilical veins and 
equine BM was collected from sternal puncture in a cohort of horses 
with ages ranging from 2 to 4 years. Then, MSC were isolated by 
density gradient centrifugation with Ficoll followed with a seed of the 
interphase in a plastic flask filled with an isolation medium to select cells 
which were able to adhere and form colonies, the MSC. After the 
appearance of several colonies, cells were detached using 
trypsin/EDTA and then reseeded at 5000 cells/cm2. 
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3. Multilineage capacity 1. Proliferative capacity 2. MSC immunophenotyping 
The cells were amplified at 
P4 and cultured at 50% of 
confluence with media 
specific for osteoblastic (n = 
4), adipocyte (n = 4) or 
chondrogenic (n = 4) 
differentiation (treated 
panels) or amplification 
medium (control panels) for 
14 days. After fixing with 
paraformaldehyde, cells 
were stained with Alizarin 
red, Oil Red O and Alcian 
blue to respectively reveal 
the presence of calcium 
deposits, lipid droplets and 
sulfated proteoglycans. 
At P4, the cells were detached and 
suspended at 10 million cells per ml 
in PBS. They were incubated with 
the indicated specific monoclonal 
antibodies, or relevant anti-IgG 
isotype controls for 30 min at 4 °C in 
a dark room. The cells were then 
washed and resuspended in PBS. 
The results are presented as the 
mean of 4 experiments. 
The MSC from the BM and UCB 
were isolated and seeded at 5000 
cells/cm2. A passage with 
trypsin/EDTA was performed every 7 
days, followed by counting and re-
seeding at the same cell density (n = 
4). The significance of the results 
was evaluated using a Mann 
Whitney test (*p < 0.05, **p < 0.01, 
***p < 0.001). 
 
Because MSC could exhibit 
differences involved in their 
chondrogenic abilities, we investigated 
a comparison of both MSC at their 
basal state. Thus, during the 
amplification of MSC we performed 
mRNA (1) and protein (2) level 
analyses. 
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MSC were cultured in monolayer 
until P4 with the amplification 
medium and their mRNA were 
extracted. The mRNA were 
estimated by RT-qPCR after 
normalization relative to the β-actin 
reference gene. The Col2a1 : 
Col1a1 ratio is shown. The results 
are represented as box plots 
(median, quartiles, extreme values) 
and the significance of the values 
was tested using a Mann-Whitney 
test (* p < 0.05). 
MSC were cultured in monolayer 
until P4 with the amplification 
medium and proteins were 
extracted. The total protein extracts 
were separated by electrophoresis 
on a 7.5% acrylamide gel under 
denaturing conditions. The proteins 
were then transferred to a PVDF 
membrane which was incubated with 
the antibodies indicated on the right.  
1. Proliferative  
capacity 
1. Comparison of mRNA expression in BM  
and UCB MSC at their basal level 
2. Comparison of protein expression in BM  
and UCB MSC at their basal level 
BM: 
-High isolation 
efficiency 
-Harvested year-
round 
-Minimally invasive 
UCB: 
-High isolation 
efficiency 
-Harvested during 
the spring 
-Not invasive 
  
(A) mRNA levels were estimated by RT-qPCR after normalization relative to the β-actin 
reference gene. The results are represented as box plots (median, quartiles, extreme values) 
and the significance of the values was tested using a Mann-Whitney test (* p < 0.05). (B) The 
total protein extracts were separated by electrophoresis on a 7.5% acrylamide gel under 
denaturing conditions. The proteins were then transferred to a PVDF membrane which was 
incubated with the antibodies indicated on the right. N : Normoxia, H : Hypoxia 
1. Effect of the chondrogenic differentiation of BM and UCB MSC  
on specific mRNA (A) and protein (B) markers of hyaline articular cartilage 
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Equine MSC derived from BM or UCB were seeded in collagen 
sponges at P4 (n = 5). They were then grown in hypoxia (3% O2) or 
normoxia (21% O2) for 14 and 28 days (D14 and D28) in the 
presence of incomplete chondrogenic medium enriched with BMP-2 
(50 ng/ml) and TGF-β1 (10 ng/ml). The D0 condition corresponds to 
MSC cultured in monolayer at P4 with the amplification medium and 
the equine articular cartilage (eAC) condition corresponds to the 
protein extracted from healthy cartilage.  
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BM and UCB MSC: 
- Multipotent 
- High proliferative 
capacitties 
-Express characteristic 
CD 
BM MSC: 
-Highest proliferative 
capacities  
-Strongest abilities to 
differentiate into 
adipocytes 
  
BM and UCB MSC: 
- Inter strain 
variabilities 
BM MSC: 
-Highest amount of 
type I collagen 
-Highest protein level of 
type II collagen 
-Largest level of 
osteoblatic markers 
  
BM and UCB MSC: 
- Hypoxia limits the 
expression of 
hypertrophic 
markers 
- Biomaterial 
colonized with ECM 
- No type I collagen at 
the vicinity of the 
nuclei 
UCB : 
-Largest amount of 
ECM 
-Type I collagen 
decreases at 28 days 
 
 BM : 
-Lower expression of 
HtrA1 
-Lower  protein amount 
of type I collagen 
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2. Assessment of the ECM  
of the neo-synthesized cartilaginous substitute 
UCB MSC BM MSC 
D14 D28 D14 D28 
At D14 and at the end of the differentiation protocol, 
sponges were embedded in paraffin and sectioned in 
4 μm-thick slices. Then immunostaining was performed in 
order to detect type I collagen or type IIB collagen. 
BM: 
 
-High isolati n efficiency 
-Harvested throughout the year 
-Minimally invasive 
 
UCB: 
 
-High isolati n efficiency 
-Harvested during the spring 
-Not invasive 
  
BM and UCB MSC: 
 
- Multipotent 
- High proliferative capacities 
- Express characteristic CD 
 
BM MSC: 
 
- Highest proliferative 
capacities  
- Strongest abilities to 
differentiate into adipocytes 
  
BM and UCB MSC: 
 
- Inter strain variabilities 
 
BM MSC: 
 
- Highest amount of type I 
collagen 
- Highest protein level of type 
II collagen 
- Largest level of osteoblatic 
markers 
  
BM and UCB MSC: 
 
- Hypoxia limits the 
expression of hypertrophic 
markers 
- Biomaterial is colonized with 
ECM 
- No type I collagen at the 
vicinity of the nuclei 
 
UCB : 
 
- Largest amount of ECM 
- Type I collagen decreases at 
28 days 
 
 BM : 
 
- Lower expression of HtrA1 
- Lower protein amount of type 
I collagen 
 
